Review



ren luciferase activity  (BMG Labtech)


Bioz Verified Symbol BMG Labtech is a verified supplier
Bioz Manufacturer Symbol BMG Labtech manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    BMG Labtech ren luciferase activity
    ( A ) Schematic representation of eIF4G homologs highlighting functional domains. The numbering is based on Gene Accession NM_182917.4 (eIF4GI), NM_001198802.2 (eIF4GII) and NM_001418.4 (eIF4GIII). Domain organization is based on Marintchev et al. . ( B ) Schematic diagram illustrating internal recruitment of 40S ribosomes and associated initiation factors (represented by a yellow star) via a λN-4G fusion, based on the tethering assay . ( C ) Schematic representation of retroviral-based expression system for ectopic production of eIF4GI in cells. Shown is the vector designed to express the middle domain of eIF4GI (amino acids 653–1131) fused to two λN domains. ( D ) Western blot denoting expression of λ–4GIm in translation extracts prepared from MSCV/λ–4GIm—infected K-2 cells (K-2/λ–4GIm). ( E ). Top: Schematic representation of bicistronic reporters used in this study. Shown are variations in the inter-cistronic region (ICR) tested. BBoxes or scrambled sequence controls (Scr) are present one (1×), three (3×) or six (6×) times, with a spacing of 26 or 52 nucleotides. Bottom: <t>Luciferase</t> production following in vitro translation of 10 μg/ml of the indicated mRNA reporters in either K-2 or K-2/λ-4GIm extracts. Values are normalized to the Scr control mRNAs of the same length and copy number (see ) and represent the average of 5 biological replicates, with each experiment performed in technical duplicates. ± SD. ns, not significant, ** P = 0.02. ( F ). Top: Schematic representation of monocistronic reporters used in this study. Bottom: Luciferase production following in vitro translation of 4 μg/ml of the indicated mRNA reporters in the indicated extracts. Values are normalized to the Scr control mRNAs of the same length. n = 5 biological replicates, ± SD.
    Ren Luciferase Activity, supplied by BMG Labtech, used in various techniques. Bioz Stars score: 99/100, based on 19063 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ren+luciferase+activity/pmc07470955-60-14-24?v=BMG+Labtech
    Average 99 stars, based on 19063 article reviews
    ren luciferase activity - by Bioz Stars, 2026-08
    99/100 stars

    Images

    1) Product Images from "RNA-tethering assay and eIF4G:eIF4A obligate dimer design uncovers multiple eIF4F functional complexes"

    Article Title: RNA-tethering assay and eIF4G:eIF4A obligate dimer design uncovers multiple eIF4F functional complexes

    Journal: Nucleic Acids Research

    doi: 10.1093/nar/gkaa646

    ( A ) Schematic representation of eIF4G homologs highlighting functional domains. The numbering is based on Gene Accession NM_182917.4 (eIF4GI), NM_001198802.2 (eIF4GII) and NM_001418.4 (eIF4GIII). Domain organization is based on Marintchev et al. . ( B ) Schematic diagram illustrating internal recruitment of 40S ribosomes and associated initiation factors (represented by a yellow star) via a λN-4G fusion, based on the tethering assay . ( C ) Schematic representation of retroviral-based expression system for ectopic production of eIF4GI in cells. Shown is the vector designed to express the middle domain of eIF4GI (amino acids 653–1131) fused to two λN domains. ( D ) Western blot denoting expression of λ–4GIm in translation extracts prepared from MSCV/λ–4GIm—infected K-2 cells (K-2/λ–4GIm). ( E ). Top: Schematic representation of bicistronic reporters used in this study. Shown are variations in the inter-cistronic region (ICR) tested. BBoxes or scrambled sequence controls (Scr) are present one (1×), three (3×) or six (6×) times, with a spacing of 26 or 52 nucleotides. Bottom: Luciferase production following in vitro translation of 10 μg/ml of the indicated mRNA reporters in either K-2 or K-2/λ-4GIm extracts. Values are normalized to the Scr control mRNAs of the same length and copy number (see ) and represent the average of 5 biological replicates, with each experiment performed in technical duplicates. ± SD. ns, not significant, ** P = 0.02. ( F ). Top: Schematic representation of monocistronic reporters used in this study. Bottom: Luciferase production following in vitro translation of 4 μg/ml of the indicated mRNA reporters in the indicated extracts. Values are normalized to the Scr control mRNAs of the same length. n = 5 biological replicates, ± SD.
    Figure Legend Snippet: ( A ) Schematic representation of eIF4G homologs highlighting functional domains. The numbering is based on Gene Accession NM_182917.4 (eIF4GI), NM_001198802.2 (eIF4GII) and NM_001418.4 (eIF4GIII). Domain organization is based on Marintchev et al. . ( B ) Schematic diagram illustrating internal recruitment of 40S ribosomes and associated initiation factors (represented by a yellow star) via a λN-4G fusion, based on the tethering assay . ( C ) Schematic representation of retroviral-based expression system for ectopic production of eIF4GI in cells. Shown is the vector designed to express the middle domain of eIF4GI (amino acids 653–1131) fused to two λN domains. ( D ) Western blot denoting expression of λ–4GIm in translation extracts prepared from MSCV/λ–4GIm—infected K-2 cells (K-2/λ–4GIm). ( E ). Top: Schematic representation of bicistronic reporters used in this study. Shown are variations in the inter-cistronic region (ICR) tested. BBoxes or scrambled sequence controls (Scr) are present one (1×), three (3×) or six (6×) times, with a spacing of 26 or 52 nucleotides. Bottom: Luciferase production following in vitro translation of 10 μg/ml of the indicated mRNA reporters in either K-2 or K-2/λ-4GIm extracts. Values are normalized to the Scr control mRNAs of the same length and copy number (see ) and represent the average of 5 biological replicates, with each experiment performed in technical duplicates. ± SD. ns, not significant, ** P = 0.02. ( F ). Top: Schematic representation of monocistronic reporters used in this study. Bottom: Luciferase production following in vitro translation of 4 μg/ml of the indicated mRNA reporters in the indicated extracts. Values are normalized to the Scr control mRNAs of the same length. n = 5 biological replicates, ± SD.

    Techniques Used: Functional Assay, Retroviral, Expressing, Plasmid Preparation, Western Blot, Infection, Sequencing, Luciferase, In Vitro, Control

    ( A ) Schematic diagram illustrating the order of transfection events in the in cellula tethering assay. Cells are first transfected with expression vectors driving synthesis of λ-fusions and GFP. One day later, mRNA reporters are transfected and luciferase values determined 12–16 h later. ( B ) Schematic representation of eIF4E and eIF4G expression constructs. Numbers in parenthesis denote amino acid positions for the eIF4G homologs. Functional domains defined in Figure are shown for reference. ( C ) Luciferase production following co-expression of the indicated monocistronic mRNAs and MSCV expression vectors in HEK293T cells. Values are normalized to cells having received empty MSCV expression vector. n = 3, ± SD. * P < 0.01; **, 0.05> P >0.01. ( D ) Western blot documenting expression levels of λ-fusions in transfected HEK293T cells. ( E ) Assessment of A-capped 3×BBox-FF mRNA levels in transfected cells by RT-qPCR. Values are expressed relative to cells having received empty MSCV/λ-SVgfp expression vector. n = 3, ±SD.
    Figure Legend Snippet: ( A ) Schematic diagram illustrating the order of transfection events in the in cellula tethering assay. Cells are first transfected with expression vectors driving synthesis of λ-fusions and GFP. One day later, mRNA reporters are transfected and luciferase values determined 12–16 h later. ( B ) Schematic representation of eIF4E and eIF4G expression constructs. Numbers in parenthesis denote amino acid positions for the eIF4G homologs. Functional domains defined in Figure are shown for reference. ( C ) Luciferase production following co-expression of the indicated monocistronic mRNAs and MSCV expression vectors in HEK293T cells. Values are normalized to cells having received empty MSCV expression vector. n = 3, ± SD. * P < 0.01; **, 0.05> P >0.01. ( D ) Western blot documenting expression levels of λ-fusions in transfected HEK293T cells. ( E ) Assessment of A-capped 3×BBox-FF mRNA levels in transfected cells by RT-qPCR. Values are expressed relative to cells having received empty MSCV/λ-SVgfp expression vector. n = 3, ±SD.

    Techniques Used: Transfection, Expressing, Luciferase, Construct, Functional Assay, Plasmid Preparation, Western Blot, Quantitative RT-PCR

    ( A ) Luciferase production following co-expression of the indicated MSCV expression vectors in HEK293T cells with 3×BBox mRNA. n = 3, ±SD. ( B ) Western blot documenting expression levels of λN fusions in transfected HEK293T cells. ( C ) Immunoprecipitations performed from cell extracts expressing the indicated FLAG-tagged λN-4E fusion proteins. Following SDS-PAGE, Western blots were performed with antibodies targeting eIF4GI. ( D ) Luciferase production following co-expression of the indicated MSCV-eIF4A expression vectors in HEK293T cells with 3×BBox mRNA. n = 3, ±SD. ( E ) Western blot documenting expression levels of λN fusions in transfected HEK293T cells. ( F ) Western blot documenting subcellular localization (C, cytoplasmic; N, nuclear) of the indicated λN fusions in transfected HEK293T cells. eEF2 and hnRNPA1 are used as loading control for cytoplasmic and nuclear fractionation, respectively.
    Figure Legend Snippet: ( A ) Luciferase production following co-expression of the indicated MSCV expression vectors in HEK293T cells with 3×BBox mRNA. n = 3, ±SD. ( B ) Western blot documenting expression levels of λN fusions in transfected HEK293T cells. ( C ) Immunoprecipitations performed from cell extracts expressing the indicated FLAG-tagged λN-4E fusion proteins. Following SDS-PAGE, Western blots were performed with antibodies targeting eIF4GI. ( D ) Luciferase production following co-expression of the indicated MSCV-eIF4A expression vectors in HEK293T cells with 3×BBox mRNA. n = 3, ±SD. ( E ) Western blot documenting expression levels of λN fusions in transfected HEK293T cells. ( F ) Western blot documenting subcellular localization (C, cytoplasmic; N, nuclear) of the indicated λN fusions in transfected HEK293T cells. eEF2 and hnRNPA1 are used as loading control for cytoplasmic and nuclear fractionation, respectively.

    Techniques Used: Luciferase, Expressing, Western Blot, Transfection, SDS Page, Control, Fractionation

    Structure-guided approach to generating orthogonal eIF4G:eIF4A pairs. ( A ) A model of the interface between human eIF4A1:eIF4GI was created by transposing the human sequence onto the yeast (y) structure (PDB accession number 2VSO) . Overview of the yeIF4G:eIF4A complex with human residues modelled at the interface. i . Residue pair eIF4GI(S738):eIF4A1(D265) forms a putative interaction in human. The identity and numbering in yeast homologs of the relevant residues are indicated in parenthesis. The amino acids targeted in human eIF4A1, as well as corresponding mutations made, are indicated. Note that the side chain of yK582 is disordered. ii . eIF4GI residues R764 and S767 form a putative interaction with eIF4A1 residue E268 in human. iii . eIF4GI residues T773 and eIF4A1 residue T298 form a putative interaction in human. iv . eIF4GI residue Q779 and/or eIF4GI residue Q783 forms a putative interaction with eIF4A1 D296 in human. v . eIF4GI residues D982 and eIF4A1 residue R45 form a putative interaction in human. ( B ) Luciferase production following co-expression of the indicated constructs in HEK293T cells with 3xBBox mRNA. Arrows refer to the increase in signal obtained with the obligate dimer pair compared to signal obtained with only the eIF4G mutant—only the largest increase is denoted in this way. Values are normalized to cells having received empty MSCV expression vector. n = 3, ± SD. ( C ). Western blot documenting expression levels of recombinant fusions in transfected HEK293T cells.
    Figure Legend Snippet: Structure-guided approach to generating orthogonal eIF4G:eIF4A pairs. ( A ) A model of the interface between human eIF4A1:eIF4GI was created by transposing the human sequence onto the yeast (y) structure (PDB accession number 2VSO) . Overview of the yeIF4G:eIF4A complex with human residues modelled at the interface. i . Residue pair eIF4GI(S738):eIF4A1(D265) forms a putative interaction in human. The identity and numbering in yeast homologs of the relevant residues are indicated in parenthesis. The amino acids targeted in human eIF4A1, as well as corresponding mutations made, are indicated. Note that the side chain of yK582 is disordered. ii . eIF4GI residues R764 and S767 form a putative interaction with eIF4A1 residue E268 in human. iii . eIF4GI residues T773 and eIF4A1 residue T298 form a putative interaction in human. iv . eIF4GI residue Q779 and/or eIF4GI residue Q783 forms a putative interaction with eIF4A1 D296 in human. v . eIF4GI residues D982 and eIF4A1 residue R45 form a putative interaction in human. ( B ) Luciferase production following co-expression of the indicated constructs in HEK293T cells with 3xBBox mRNA. Arrows refer to the increase in signal obtained with the obligate dimer pair compared to signal obtained with only the eIF4G mutant—only the largest increase is denoted in this way. Values are normalized to cells having received empty MSCV expression vector. n = 3, ± SD. ( C ). Western blot documenting expression levels of recombinant fusions in transfected HEK293T cells.

    Techniques Used: Sequencing, Residue, Luciferase, Expressing, Construct, Mutagenesis, Plasmid Preparation, Western Blot, Recombinant, Transfection



    Similar Products

    98
    Vazyme Biotech Co renilla luciferase ren activities
    Renilla Luciferase Ren Activities, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ren+luciferase+activity/pm41977716-223-3-15?v=Vazyme+Biotech+Co
    Average 98 stars, based on 1 article reviews
    renilla luciferase ren activities - by Bioz Stars, 2026-08
    98/100 stars
      Buy from Supplier

    86
    Novogene renilla luciferase ren activity
    Renilla Luciferase Ren Activity, supplied by Novogene, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ren+luciferase+activity/10__1093_slash_hr_slash_uhag089-223-5-9?v=Novogene
    Average 86 stars, based on 1 article reviews
    renilla luciferase ren activity - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    86
    Yeasen Biotechnology renilla ren luciferase activities
    Renilla Ren Luciferase Activities, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ren+luciferase+activity/pmc12793751-102-23-32?v=Yeasen+Biotechnology
    Average 86 stars, based on 1 article reviews
    renilla ren luciferase activities - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    90
    Yeasen Biotechnology firefly and renilla (ren) luciferase activities
    Firefly And Renilla (Ren) Luciferase Activities, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ren+luciferase+activity/pm39701377-106-21-32?v=Yeasen+Biotechnology
    Average 90 stars, based on 1 article reviews
    firefly and renilla (ren) luciferase activities - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    96
    Vazyme Biotech Co renilla luciferase ren luciferase activities
    Renilla Luciferase Ren Luciferase Activities, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ren+luciferase+activity/pm39000081-454-10-22?v=Vazyme+Biotech+Co
    Average 96 stars, based on 1 article reviews
    renilla luciferase ren luciferase activities - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    90
    Promega both luciferase (ff-luc) and renilla luciferase (ren-luc) activities were measured
    Both Luciferase (Ff Luc) And Renilla Luciferase (Ren Luc) Activities Were Measured, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ren+luciferase+activity/bio_rxiv__2021__07__20__453038-198-19-33?v=Promega
    Average 90 stars, based on 1 article reviews
    both luciferase (ff-luc) and renilla luciferase (ren-luc) activities were measured - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    99
    BMG Labtech ren luciferase activity
    ( A ) Schematic representation of eIF4G homologs highlighting functional domains. The numbering is based on Gene Accession NM_182917.4 (eIF4GI), NM_001198802.2 (eIF4GII) and NM_001418.4 (eIF4GIII). Domain organization is based on Marintchev et al. . ( B ) Schematic diagram illustrating internal recruitment of 40S ribosomes and associated initiation factors (represented by a yellow star) via a λN-4G fusion, based on the tethering assay . ( C ) Schematic representation of retroviral-based expression system for ectopic production of eIF4GI in cells. Shown is the vector designed to express the middle domain of eIF4GI (amino acids 653–1131) fused to two λN domains. ( D ) Western blot denoting expression of λ–4GIm in translation extracts prepared from MSCV/λ–4GIm—infected K-2 cells (K-2/λ–4GIm). ( E ). Top: Schematic representation of bicistronic reporters used in this study. Shown are variations in the inter-cistronic region (ICR) tested. BBoxes or scrambled sequence controls (Scr) are present one (1×), three (3×) or six (6×) times, with a spacing of 26 or 52 nucleotides. Bottom: <t>Luciferase</t> production following in vitro translation of 10 μg/ml of the indicated mRNA reporters in either K-2 or K-2/λ-4GIm extracts. Values are normalized to the Scr control mRNAs of the same length and copy number (see ) and represent the average of 5 biological replicates, with each experiment performed in technical duplicates. ± SD. ns, not significant, ** P = 0.02. ( F ). Top: Schematic representation of monocistronic reporters used in this study. Bottom: Luciferase production following in vitro translation of 4 μg/ml of the indicated mRNA reporters in the indicated extracts. Values are normalized to the Scr control mRNAs of the same length. n = 5 biological replicates, ± SD.
    Ren Luciferase Activity, supplied by BMG Labtech, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ren+luciferase+activity/pmc07470955-60-14-24?v=BMG+Labtech
    Average 99 stars, based on 1 article reviews
    ren luciferase activity - by Bioz Stars, 2026-08
    99/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Schematic representation of eIF4G homologs highlighting functional domains. The numbering is based on Gene Accession NM_182917.4 (eIF4GI), NM_001198802.2 (eIF4GII) and NM_001418.4 (eIF4GIII). Domain organization is based on Marintchev et al. . ( B ) Schematic diagram illustrating internal recruitment of 40S ribosomes and associated initiation factors (represented by a yellow star) via a λN-4G fusion, based on the tethering assay . ( C ) Schematic representation of retroviral-based expression system for ectopic production of eIF4GI in cells. Shown is the vector designed to express the middle domain of eIF4GI (amino acids 653–1131) fused to two λN domains. ( D ) Western blot denoting expression of λ–4GIm in translation extracts prepared from MSCV/λ–4GIm—infected K-2 cells (K-2/λ–4GIm). ( E ). Top: Schematic representation of bicistronic reporters used in this study. Shown are variations in the inter-cistronic region (ICR) tested. BBoxes or scrambled sequence controls (Scr) are present one (1×), three (3×) or six (6×) times, with a spacing of 26 or 52 nucleotides. Bottom: Luciferase production following in vitro translation of 10 μg/ml of the indicated mRNA reporters in either K-2 or K-2/λ-4GIm extracts. Values are normalized to the Scr control mRNAs of the same length and copy number (see ) and represent the average of 5 biological replicates, with each experiment performed in technical duplicates. ± SD. ns, not significant, ** P = 0.02. ( F ). Top: Schematic representation of monocistronic reporters used in this study. Bottom: Luciferase production following in vitro translation of 4 μg/ml of the indicated mRNA reporters in the indicated extracts. Values are normalized to the Scr control mRNAs of the same length. n = 5 biological replicates, ± SD.

    Journal: Nucleic Acids Research

    Article Title: RNA-tethering assay and eIF4G:eIF4A obligate dimer design uncovers multiple eIF4F functional complexes

    doi: 10.1093/nar/gkaa646

    Figure Lengend Snippet: ( A ) Schematic representation of eIF4G homologs highlighting functional domains. The numbering is based on Gene Accession NM_182917.4 (eIF4GI), NM_001198802.2 (eIF4GII) and NM_001418.4 (eIF4GIII). Domain organization is based on Marintchev et al. . ( B ) Schematic diagram illustrating internal recruitment of 40S ribosomes and associated initiation factors (represented by a yellow star) via a λN-4G fusion, based on the tethering assay . ( C ) Schematic representation of retroviral-based expression system for ectopic production of eIF4GI in cells. Shown is the vector designed to express the middle domain of eIF4GI (amino acids 653–1131) fused to two λN domains. ( D ) Western blot denoting expression of λ–4GIm in translation extracts prepared from MSCV/λ–4GIm—infected K-2 cells (K-2/λ–4GIm). ( E ). Top: Schematic representation of bicistronic reporters used in this study. Shown are variations in the inter-cistronic region (ICR) tested. BBoxes or scrambled sequence controls (Scr) are present one (1×), three (3×) or six (6×) times, with a spacing of 26 or 52 nucleotides. Bottom: Luciferase production following in vitro translation of 10 μg/ml of the indicated mRNA reporters in either K-2 or K-2/λ-4GIm extracts. Values are normalized to the Scr control mRNAs of the same length and copy number (see ) and represent the average of 5 biological replicates, with each experiment performed in technical duplicates. ± SD. ns, not significant, ** P = 0.02. ( F ). Top: Schematic representation of monocistronic reporters used in this study. Bottom: Luciferase production following in vitro translation of 4 μg/ml of the indicated mRNA reporters in the indicated extracts. Values are normalized to the Scr control mRNAs of the same length. n = 5 biological replicates, ± SD.

    Article Snippet: Cells were lysed 12–16 h later using Passive Lysis Buffer (Promega) and FF and Ren luciferase activity determined on a Fluostar 96-well plate reader BMG Labtech ( ).

    Techniques: Functional Assay, Retroviral, Expressing, Plasmid Preparation, Western Blot, Infection, Sequencing, Luciferase, In Vitro, Control

    ( A ) Schematic diagram illustrating the order of transfection events in the in cellula tethering assay. Cells are first transfected with expression vectors driving synthesis of λ-fusions and GFP. One day later, mRNA reporters are transfected and luciferase values determined 12–16 h later. ( B ) Schematic representation of eIF4E and eIF4G expression constructs. Numbers in parenthesis denote amino acid positions for the eIF4G homologs. Functional domains defined in Figure are shown for reference. ( C ) Luciferase production following co-expression of the indicated monocistronic mRNAs and MSCV expression vectors in HEK293T cells. Values are normalized to cells having received empty MSCV expression vector. n = 3, ± SD. * P < 0.01; **, 0.05> P >0.01. ( D ) Western blot documenting expression levels of λ-fusions in transfected HEK293T cells. ( E ) Assessment of A-capped 3×BBox-FF mRNA levels in transfected cells by RT-qPCR. Values are expressed relative to cells having received empty MSCV/λ-SVgfp expression vector. n = 3, ±SD.

    Journal: Nucleic Acids Research

    Article Title: RNA-tethering assay and eIF4G:eIF4A obligate dimer design uncovers multiple eIF4F functional complexes

    doi: 10.1093/nar/gkaa646

    Figure Lengend Snippet: ( A ) Schematic diagram illustrating the order of transfection events in the in cellula tethering assay. Cells are first transfected with expression vectors driving synthesis of λ-fusions and GFP. One day later, mRNA reporters are transfected and luciferase values determined 12–16 h later. ( B ) Schematic representation of eIF4E and eIF4G expression constructs. Numbers in parenthesis denote amino acid positions for the eIF4G homologs. Functional domains defined in Figure are shown for reference. ( C ) Luciferase production following co-expression of the indicated monocistronic mRNAs and MSCV expression vectors in HEK293T cells. Values are normalized to cells having received empty MSCV expression vector. n = 3, ± SD. * P < 0.01; **, 0.05> P >0.01. ( D ) Western blot documenting expression levels of λ-fusions in transfected HEK293T cells. ( E ) Assessment of A-capped 3×BBox-FF mRNA levels in transfected cells by RT-qPCR. Values are expressed relative to cells having received empty MSCV/λ-SVgfp expression vector. n = 3, ±SD.

    Article Snippet: Cells were lysed 12–16 h later using Passive Lysis Buffer (Promega) and FF and Ren luciferase activity determined on a Fluostar 96-well plate reader BMG Labtech ( ).

    Techniques: Transfection, Expressing, Luciferase, Construct, Functional Assay, Plasmid Preparation, Western Blot, Quantitative RT-PCR

    ( A ) Luciferase production following co-expression of the indicated MSCV expression vectors in HEK293T cells with 3×BBox mRNA. n = 3, ±SD. ( B ) Western blot documenting expression levels of λN fusions in transfected HEK293T cells. ( C ) Immunoprecipitations performed from cell extracts expressing the indicated FLAG-tagged λN-4E fusion proteins. Following SDS-PAGE, Western blots were performed with antibodies targeting eIF4GI. ( D ) Luciferase production following co-expression of the indicated MSCV-eIF4A expression vectors in HEK293T cells with 3×BBox mRNA. n = 3, ±SD. ( E ) Western blot documenting expression levels of λN fusions in transfected HEK293T cells. ( F ) Western blot documenting subcellular localization (C, cytoplasmic; N, nuclear) of the indicated λN fusions in transfected HEK293T cells. eEF2 and hnRNPA1 are used as loading control for cytoplasmic and nuclear fractionation, respectively.

    Journal: Nucleic Acids Research

    Article Title: RNA-tethering assay and eIF4G:eIF4A obligate dimer design uncovers multiple eIF4F functional complexes

    doi: 10.1093/nar/gkaa646

    Figure Lengend Snippet: ( A ) Luciferase production following co-expression of the indicated MSCV expression vectors in HEK293T cells with 3×BBox mRNA. n = 3, ±SD. ( B ) Western blot documenting expression levels of λN fusions in transfected HEK293T cells. ( C ) Immunoprecipitations performed from cell extracts expressing the indicated FLAG-tagged λN-4E fusion proteins. Following SDS-PAGE, Western blots were performed with antibodies targeting eIF4GI. ( D ) Luciferase production following co-expression of the indicated MSCV-eIF4A expression vectors in HEK293T cells with 3×BBox mRNA. n = 3, ±SD. ( E ) Western blot documenting expression levels of λN fusions in transfected HEK293T cells. ( F ) Western blot documenting subcellular localization (C, cytoplasmic; N, nuclear) of the indicated λN fusions in transfected HEK293T cells. eEF2 and hnRNPA1 are used as loading control for cytoplasmic and nuclear fractionation, respectively.

    Article Snippet: Cells were lysed 12–16 h later using Passive Lysis Buffer (Promega) and FF and Ren luciferase activity determined on a Fluostar 96-well plate reader BMG Labtech ( ).

    Techniques: Luciferase, Expressing, Western Blot, Transfection, SDS Page, Control, Fractionation

    Structure-guided approach to generating orthogonal eIF4G:eIF4A pairs. ( A ) A model of the interface between human eIF4A1:eIF4GI was created by transposing the human sequence onto the yeast (y) structure (PDB accession number 2VSO) . Overview of the yeIF4G:eIF4A complex with human residues modelled at the interface. i . Residue pair eIF4GI(S738):eIF4A1(D265) forms a putative interaction in human. The identity and numbering in yeast homologs of the relevant residues are indicated in parenthesis. The amino acids targeted in human eIF4A1, as well as corresponding mutations made, are indicated. Note that the side chain of yK582 is disordered. ii . eIF4GI residues R764 and S767 form a putative interaction with eIF4A1 residue E268 in human. iii . eIF4GI residues T773 and eIF4A1 residue T298 form a putative interaction in human. iv . eIF4GI residue Q779 and/or eIF4GI residue Q783 forms a putative interaction with eIF4A1 D296 in human. v . eIF4GI residues D982 and eIF4A1 residue R45 form a putative interaction in human. ( B ) Luciferase production following co-expression of the indicated constructs in HEK293T cells with 3xBBox mRNA. Arrows refer to the increase in signal obtained with the obligate dimer pair compared to signal obtained with only the eIF4G mutant—only the largest increase is denoted in this way. Values are normalized to cells having received empty MSCV expression vector. n = 3, ± SD. ( C ). Western blot documenting expression levels of recombinant fusions in transfected HEK293T cells.

    Journal: Nucleic Acids Research

    Article Title: RNA-tethering assay and eIF4G:eIF4A obligate dimer design uncovers multiple eIF4F functional complexes

    doi: 10.1093/nar/gkaa646

    Figure Lengend Snippet: Structure-guided approach to generating orthogonal eIF4G:eIF4A pairs. ( A ) A model of the interface between human eIF4A1:eIF4GI was created by transposing the human sequence onto the yeast (y) structure (PDB accession number 2VSO) . Overview of the yeIF4G:eIF4A complex with human residues modelled at the interface. i . Residue pair eIF4GI(S738):eIF4A1(D265) forms a putative interaction in human. The identity and numbering in yeast homologs of the relevant residues are indicated in parenthesis. The amino acids targeted in human eIF4A1, as well as corresponding mutations made, are indicated. Note that the side chain of yK582 is disordered. ii . eIF4GI residues R764 and S767 form a putative interaction with eIF4A1 residue E268 in human. iii . eIF4GI residues T773 and eIF4A1 residue T298 form a putative interaction in human. iv . eIF4GI residue Q779 and/or eIF4GI residue Q783 forms a putative interaction with eIF4A1 D296 in human. v . eIF4GI residues D982 and eIF4A1 residue R45 form a putative interaction in human. ( B ) Luciferase production following co-expression of the indicated constructs in HEK293T cells with 3xBBox mRNA. Arrows refer to the increase in signal obtained with the obligate dimer pair compared to signal obtained with only the eIF4G mutant—only the largest increase is denoted in this way. Values are normalized to cells having received empty MSCV expression vector. n = 3, ± SD. ( C ). Western blot documenting expression levels of recombinant fusions in transfected HEK293T cells.

    Article Snippet: Cells were lysed 12–16 h later using Passive Lysis Buffer (Promega) and FF and Ren luciferase activity determined on a Fluostar 96-well plate reader BMG Labtech ( ).

    Techniques: Sequencing, Residue, Luciferase, Expressing, Construct, Mutagenesis, Plasmid Preparation, Western Blot, Recombinant, Transfection